FunPep Company Limited Logo

FunPep Company Limited

4881 | T

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
Japan
Address:
茨木市彩都あさぎ七丁目7−15
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

FunPep Company Limited is a pioneering Japanese biotechnology firm specializing in the development of peptide-based pharmaceuticals. Based in Tokyo, the company focuses on harnessing the therapeutic potential of peptides, which are vital in regulating various bodily functions. FunPep's innovative pipeline includes allergy vaccines and functional peptides, with ongoing clinical trials aimed at inducing immune responses and advancing next-generation formulation technologies. The company actively engages in strategic collaborations, such as its recent partnership with BIOASTER, to enhance its research and development capabilities. With a commitment to improving healthcare through cutting-edge science, FunPep stands at the forefront of the pharmaceutical landscape in Japan and beyond.

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for FunPep Company Limited. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-04-01 08:30
Regulatory News Service
臨時報告書
Japanese 23.2 KB
2025-03-28 08:16
Regulatory News Service
確認書
Japanese 8.5 KB
2025-03-28 08:15
Annual Report
有価証券報告書-第12期(2024/01/01-2024/12/31)
Japanese 1.6 MB
2025-03-28 08:15
Regulatory News Service
内部統制報告書-第12期(2024/01/01-2024/12/31)
Japanese 23.6 KB
2025-02-21 07:30
Prospectus
有価証券届出書(組込方式)
Japanese 447.3 KB
2024-08-08 09:01
Regulatory News Service
確認書
Japanese 8.4 KB
2024-08-08 09:00
Interim Report
半期報告書-第12期(2024/01/01-2024/12/31)
Japanese 283.1 KB
2024-08-08 03:00
Regulatory News Service
臨時報告書
Japanese 21.3 KB
2024-07-05 08:05
Prospectus
有価証券届出書(組込方式)
Japanese 391.3 KB
2024-05-13 08:00
Regulatory News Service
確認書
Japanese 8.4 KB
2024-05-13 08:00
Quarterly Report
四半期報告書-第12期第1四半期(2024/01/01-2024/03/31)
Japanese 238.2 KB
2024-04-01 08:05
Regulatory News Service
臨時報告書
Japanese 27.7 KB
2024-03-28 07:15
Regulatory News Service
確認書
Japanese 8.5 KB
2024-03-28 07:15
Annual Report
有価証券報告書-第11期(2023/01/01-2023/12/31)
Japanese 1.6 MB
2024-03-28 07:15
Regulatory News Service
内部統制報告書-第11期(2023/01/01-2023/12/31)
Japanese 23.5 KB

Automate Your Workflow. Get a real-time feed of all FunPep Company Limited filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for FunPep Company Limited via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
4BASEBIO PLC Logo
Manufactures GMP-compliant synthetic DNA for advanced therapies, vaccines, and cell/gene therapies.
United Kingdom 4BB
ABINGDON HEALTH PLC Logo
A CDMO for lateral flow rapid tests, providing end-to-end services and its own branded products.
United Kingdom ABDX
ABIONYX Pharma Logo
Biotech developing lipid-based therapies for rare renal and ophthalmological diseases.
France ABNX
AB Science Logo
Develops protein kinase inhibitors for oncology, neuro, and inflammatory diseases.
France AB
AcuCort AB Logo
Develops a rapid oral film for acute allergies, croup, and chemo-induced nausea.
Sweden ACUC
Advicenne Logo
Develops and commercializes therapies for rare renal diseases for patients of all ages.
France ALDVI
AegirBio AB Logo
Makes saliva-based diagnostics accessible for at-home & pro health & drug monitoring.
Sweden AEGIR
Aelis Farma Logo
Developing novel CB1 receptor inhibitors for treating brain and CNS disorders.
France AELIS
AGRONOMICS LIMITED Logo Isle of Man ANIC
ALK-Abelló Logo
Develops allergy immunotherapy (AIT) and emergency treatments for severe allergies.
Denmark ALK